Course Image Hepatitis B s100 Prescriber course – Part 1: Online Modules (3 hours)

These online learning modules are designed for registrants of the Hepatitis B s100 Prescriber Course and are a prerequisite for the one day face-to-face training.

Module 1 covers priority populations, testing and diagnosis of hepatitis B. Participants will review priority populations for hepatitis B screening, identify which tests are to be ordered, and be able to interpret serology to determine if a patient is susceptible, vaccinated, previously exposed, and has acute or chronic hepatitis B infection.

Modules 2 through 6 follow a family through their various diagnoses of hepatitis B. Participants will follow the journey of each family member covering issues such as; diagnosis, assessment and initial management; HBV, advanced liver disease and HCC; HBV and immune suppression; HBV and pregnancy

Each module includes opportunities for self-assessment to ensure learning objectives are met.

Target audience: GPs
CPD: RACGP accredited and has been awarded 7 Category 2 QI&CPD points
Type: eLearning Module (2015)

Course Image Hepatitis B: Clinical Management Audit

Of people living with hepatitis B (chronic hepatitis B, CHB) in Australia, 43% remain undiagnosed. Without appropriate management, up to 1 in 4 people with CHB will die from liver cancer or liver failure. Timely diagnosis and clinical management, including the prescription of antiviral therapy, can prevent cancer and save lives. 

Hepatitis B can now be managed as a chronic condition in general practice. The aim of this audit and training is to address some of the major issues in the management of hepatitis B as a long-term condition and improve communication between general practitioners, specialists and patients. 

Completion of the Hepatitis B: Clinical Management Audit and Training attracts
40 RACGP audit points

Course Image Hepatitis training for GPs and health care professionals with Aboriginal patients

This online learning module provides participants with the necessary knowledge and skills to more confidently manage their Aboriginal clients with hepatitis B and C. It outlines the public health aspects and clinical management of hepatitis B and C and advocates a proactive approach to health care for Aboriginal clients.

Target audience: Clinical care teams working with Aboriginal clients in AMSs/ACCHOs or other primary health care settings. This course will be of particular benefit to GPs, Nurses and Aboriginal Health Workers.
CPD: RACGP 3 Category 2 QI&CPD points.
Type: Videos (written 2010, updated 2014)
Funded by: National Partnership Agreement in Indigenous Health, Department of Health 

Course Image Preventing liver cancer through diagnosis and management of hepatitis B

This four-part module discusses the role general practitioners can play in the diagnosis and management of hepatitis B. It also highlights the link between hepatitis B and liver cancer. Liver cancer, most of which is caused by viral hepatitis, is now in the top 10 causes of cancer death and most people diagnosed with liver cancer in Australia die within one to two years – many in the first month after diagnosis. Appropriate management and treatment of hepatitis B can prevent liver cancer.

Target audience: General Practitioners (GPs); however, practice nurses and other health professionals may also find it useful.
CPD: 2 RACGP QI&CPD Category 2 points in the 2014-2016 triennium.
Type: Online Module that includes short video clips
Funded by: Australian Government, Department of Health and developed in conjunction with Cancer Council NSW.

Hepatitis B and C sessions from the leading multidisciplinary Viral Hepatitis conference in Australasia. Covering topics on viral hepatitis clinical care, epidemiology, public health and prevention.

Target audience: General practitioners, nurses, infectious disease physicians, gastroenterologists, community Workers, educators, researchers, policy officers and health promotion staff.

CPD: Community HCV and HBV s100 Prescribers will receive 1 HCV CPD point
Type:  Videos (2014)
Funded by: Australian Government Department of Health.